Based in All, Dot Lab is a startup. Brouky records 1 investor associated with the company.
Dot Lab develops DotEndo, a non-invasive blood test that uses biomarkers and biostatistics to aid in the diagnosis of active endometriosis across all stages of the disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.